289 related articles for article (PubMed ID: 31697646)
1. Catalpol induces autophagy and attenuates liver steatosis in ob/ob and high-fat diet-induced obese mice.
Ren H; Wang D; Zhang L; Kang X; Li Y; Zhou X; Yuan G
Aging (Albany NY); 2019 Nov; 11(21):9461-9477. PubMed ID: 31697646
[TBL] [Abstract][Full Text] [Related]
2. Maresin 1 mitigates liver steatosis in ob/ob and diet-induced obese mice.
Laiglesia LM; Lorente-Cebrián S; Martínez-Fernández L; Sáinz N; Prieto-Hontoria PL; Burrell MA; Rodríguez-Ortigosa CM; Martínez JA; Moreno-Aliaga MJ
Int J Obes (Lond); 2018 Mar; 42(3):572-579. PubMed ID: 28895586
[TBL] [Abstract][Full Text] [Related]
3. Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy.
Wang Y; Zhao H; Li X; Wang Q; Yan M; Zhang H; Zhao T; Zhang N; Zhang P; Peng L; Li P
J Nutr Biochem; 2019 Nov; 73():108214. PubMed ID: 31520816
[TBL] [Abstract][Full Text] [Related]
4. Barley sprout extracts reduce hepatic lipid accumulation in ethanol-fed mice by activating hepatic AMP-activated protein kinase.
Kim YJ; Hwang SH; Jia Y; Seo WD; Lee SJ
Food Res Int; 2017 Nov; 101():209-217. PubMed ID: 28941686
[TBL] [Abstract][Full Text] [Related]
5. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
[TBL] [Abstract][Full Text] [Related]
6. Ajugol enhances TFEB-mediated lysosome biogenesis and lipophagy to alleviate non-alcoholic fatty liver disease.
Zhang H; Lu J; Liu H; Guan L; Xu S; Wang Z; Qiu Y; Liu H; Peng L; Men X
Pharmacol Res; 2021 Dec; 174():105964. PubMed ID: 34732369
[TBL] [Abstract][Full Text] [Related]
7. The fruit of Acanthopanax senticosus (Rupr. et Maxim.) Harms improves insulin resistance and hepatic lipid accumulation by modulation of liver adenosine monophosphate-activated protein kinase activity and lipogenic gene expression in high-fat diet-fed obese mice.
Saito T; Nishida M; Saito M; Tanabe A; Eitsuka T; Yuan SH; Ikekawa N; Nishida H
Nutr Res; 2016 Oct; 36(10):1090-1097. PubMed ID: 27865350
[TBL] [Abstract][Full Text] [Related]
8. Catalpol Attenuates Hepatic Steatosis by Regulating Lipid Metabolism via AMP-Activated Protein Kinase Activation.
Tian X; Ru Q; Xiong Q; Wen R; Chen Y
Biomed Res Int; 2020; 2020():6708061. PubMed ID: 32420361
[TBL] [Abstract][Full Text] [Related]
9. Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition.
Kim SH; Kim G; Han DH; Lee M; Kim I; Kim B; Kim KH; Song YM; Yoo JE; Wang HJ; Bae SH; Lee YH; Lee BW; Kang ES; Cha BS; Lee MS
Autophagy; 2017 Oct; 13(10):1767-1781. PubMed ID: 28933629
[TBL] [Abstract][Full Text] [Related]
10. Fenofibrate, a PPARα agonist, reduces hepatic fat accumulation through the upregulation of TFEB-mediated lipophagy.
Yoo J; Jeong IK; Ahn KJ; Chung HY; Hwang YC
Metabolism; 2021 Jul; 120():154798. PubMed ID: 33984335
[TBL] [Abstract][Full Text] [Related]
11. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
12.
Lee HY; Lee GH; Yoon Y; Chae HJ
Am J Chin Med; 2019; 47(6):1253-1270. PubMed ID: 31488034
[TBL] [Abstract][Full Text] [Related]
13. High-fat diet overfeeding promotes nondetrimental liver steatosis in female mice.
Arisqueta L; Navarro-Imaz H; Labiano I; Rueda Y; Fresnedo O
Am J Physiol Gastrointest Liver Physiol; 2018 Nov; 315(5):G772-G780. PubMed ID: 30095299
[TBL] [Abstract][Full Text] [Related]
14. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
[TBL] [Abstract][Full Text] [Related]
15. Catalpol ameliorates hepatic insulin resistance in type 2 diabetes through acting on AMPK/NOX4/PI3K/AKT pathway.
Yan J; Wang C; Jin Y; Meng Q; Liu Q; Liu Z; Liu K; Sun H
Pharmacol Res; 2018 Apr; 130():466-480. PubMed ID: 29284152
[TBL] [Abstract][Full Text] [Related]
16. Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway.
Song YM; Lee YH; Kim JW; Ham DS; Kang ES; Cha BS; Lee HC; Lee BW
Autophagy; 2015; 11(1):46-59. PubMed ID: 25484077
[TBL] [Abstract][Full Text] [Related]
17. Madecassoside ameliorates hepatic steatosis in high-fat diet-fed mice through AMPK/autophagy-mediated suppression of ER stress.
Choi SW; Cho W; Oh H; Abd El-Aty AM; Hong SA; Hong M; Jeong JH; Jung TW
Biochem Pharmacol; 2023 Nov; 217():115815. PubMed ID: 37741512
[TBL] [Abstract][Full Text] [Related]
18. Hexacosanol reduces plasma and hepatic cholesterol by activation of AMP-activated protein kinase and suppression of sterol regulatory element-binding protein-2 in HepG2 and C57BL/6J mice.
Lee JH; Jia Y; Thach TT; Han Y; Kim B; Wu C; Kim Y; Seo WD; Lee SJ
Nutr Res; 2017 Jul; 43():89-99. PubMed ID: 28676202
[TBL] [Abstract][Full Text] [Related]
19. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
He Q; Sha S; Sun L; Zhang J; Dong M
Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
[TBL] [Abstract][Full Text] [Related]
20. Sesamol Alleviates Obesity-Related Hepatic Steatosis via Activating Hepatic PKA Pathway.
Xu HY; Yu L; Chen JH; Yang LN; Lin C; Shi XQ; Qin H
Nutrients; 2020 Jan; 12(2):. PubMed ID: 31991934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]